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Background
In primary care in the UK, there are 10 000 family
practices, and 30 000 family physicians (GPs), inde-
pendent contractors who provide 80–90% of care to
registered patients. Almost every practice uses a clin-
ical computer system, and around half are now
‘paperlight’, and use the system during the patient
consultation.
The main driver for this ubiquitous primary care
uptake of clinical computer systems is that they
support both the clinical and business processes of
general practice. Alongside this are the various
government initiatives over the last 20 years, from
the accreditation of systems,1 through data-driven
contracts from 19902 to the present,3 to the major
information strategies in the NHS.4–6
ABSTRACT
This paper, presented as a panel at the American
Medical Informatics Association (AMIA) Fall Sym-
posium 2006, explores a number of secondary uses
of primary care clinical data derived from point-of-
care systems, and the issues arising from those uses.
The authors (from the USA and the UK) describe,
compare and contrast some secondary uses: pay-
for-performance, public disclosure, clinical audit,
health resource planning, and clinical system usage;
in various environments: national health system,
network of small family practice oﬃces, and uni-
versity teaching centres. In the UK, such data are
now being used in pay-for-performance for GPs,
and approximately 35% of their salary has been put
at risk, which has resulted in close scrutiny. In the
USA, pay-for-performance is at an earlier stage but
is increasingly prevalent and continues to be hotly
debated. Some of the issues that arise from these
uses of clinical data – data quality including accu-
racy, comparability, perverse incentives, eﬀect of
secondary uses on care provision, and security and
conﬁdentiality among others – were discussed.
Finally, options and opportunities for improving
secondary uses of data in the light of the issues
covered earlier were considered.
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The systemmarket has changed considerably in the
last 20 years, from 120 suppliers in 1985 to seven now;
one of those supplies three diﬀerent systems and
covers 55% of the market.
In UK primary care, the functions of clinical com-
puter systems are shown in Box 1.
Uses of primary care clinical data
Primary care clinical data contained in or derived
from those systems are used for a variety of purposes.
Their primary use is to support direct clinical care, and
most practitioners now use electronic patient records
during the consultation, both to guide and record
clinical care. In addition, there is a broad range of
secondary uses of the data: support of preventive care
and health promotion; clinical audit and clinical gov-
ernance; national screening and preventive campaigns;
audits against national standards; payment; national
statistics; planning future services; and resource allo-
cation. Examples of some of these uses are given
below.
National audit
The National Diabetes Audit standards are built from
the Diabetes National Service Framework;7 the audit
combines anonymised patient-level data from general
practice and hospitals. The second annual audit8
report (September 2006) includes data from 500 000
patient records covering 43% of practices. It estimates
that 20% of diabetes patients remain undiagnosed,
particularly women; it also calculates the increased
risk of speciﬁc complications of diabetes, for example,
a ﬁve-fold increase in risk of angina. The process of
care for patients with diabetes shows 80% of patients
having most routine checks. Intermediate outcome
measures showed 58%with good blood glucose control;
88%with BP lower than 160/100mmHg; 24%with BP
lower than 135/75 mmHg; 68% with an acceptable
cholesterol level; it also replicated the heart disease
ﬁnding of undertreatment with statins of women.9,10
Monitoring of preventive care
National preventive campaigns using data direct from
primary care clinical systems include the inﬂuenza and
pneumococcal vaccine uptake surveys; in 2005–2006
75.3% of patients aged 65 and over were vaccinated
against inﬂuenza, and 48%of those under 65 classiﬁed
as ‘at risk’ were vaccinated.11 Pneumococcal vacci-
nation showed similarly good results, with 64.4% of
patients aged 65 and over having been vaccinated.12
These results were obtained not least because tools
were provided to allow practices easily to identify and
vaccinate those patients who were eligible because of
age or pre-existing conditions.
Monitoring of health status
The Department of Health requires quarterly moni-
toring and reporting of smoking and obesity rates; in
2005 data were reported on 39 million patients aged
between 15 and 75. Smoking status (recorded in the
last 15 months) was available for 58% of those patients;
25% of those with status recorded were smokers (14%
of the populationbetween15 and75). BMIwas recorded
(in the last 15 months) for only 30% of the 15–75
population; of those 28% were recorded as obese (i.e.
8% of the population aged 15–75; Dr Michael Soljak,
personal communication). These results suggest pref-
erential recording of those who smoke and those who
are obese. From a clinical perspective these ﬁndings
are easily explicable: if a patient has never smoked, it is
unlikely that they will start the habit, soGPs do not ask
them every year and record their response; likewise, if
a patient does not look obese, the GP will not weigh
them and the system will therefore not calculate and
record their BMI. These measures have been reﬁned
(at least for smoking status) for the 2007 data collec-
tion.
Quality and Outcomes Framework
The newGMSContract includes a pay-for-performance
scheme known as the Quality and Outcomes Frame-
work; 30–40%of practice income depends on achieve-
ment against 136 quality indicators, including
76 clinical indicators covering the most frequently-
encountered chronic conditions. The indicators were
developed by an expert group of ‘quality gurus’. Such
indicators are not always computable, however: what
started out as ‘The percentage of patients receiving
treatment for hypertension whose blood pressure is
150/90’ became ‘The percentage of patients with [a
Box 1 Characteristics of GP clinical
computer systems
. Used with patient at oﬃce visit – clinically-
focused
. Structured and coded records
. Electronic prescribing
. Some decision support (warnings, reminders,
contraindications)
. Electronic lab results
. Half practices are paperlight
. National registration system linked with PAP
smear and mammography screening systems,
and childhood vaccination system
. Sophisticated reporting tools
. No billing
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recorded diagnosis of] hypertension in whom the last
blood pressure (measured in the last 9months) is 150/
90 or less’. Each indicator is fully deﬁned by ‘business
rules’ which are used by clinical system suppliers to
create validated search routines to provide the data for
the measurement of achievement.13
It is possible to ‘exception report’ patients for the
following reasons: patient refusal; not clinically ap-
propriate; newly-diagnosed or recently registered;
already on maximum dose of medication. Clearly,
there is potential for gaming. For most of the indi-
cators the measurement period is 15 months, so
January–March clinical activity can be counted in
two years; batch data entry can be used for all patients
with a condition; minimising prevalence could appear
tomaximise process and outcome achievement (how-
ever, this last is adjusted using ‘national prevalence’);
and over-use of exception reporting codes (though
practices who use such codes frequently are required
to justify their usage).
Practices have performedwell on thesemeasures: in
2004–2005, 50% of practices achieved maximum
points; in 2005–2006, 97.1% of practices achieved
maximum points.14
Secondary uses of clinical data at
Partners Healthcare
Partners Healthcare is a large integrated healthcare
delivery system in northeastern USA. It includes
Brigham and Women’s Hospital, the Massachusetts
General Hospital, several smaller hospitals, and a large
number of physicians from the greater community.
Partners has long prided itself on delivering high-
quality care and doing outstanding research, but until
recently the organisation had relatively limited re-
sources for actually measuring quality, although that
has begun to change. Under the leadership of Chief
Executive Oﬃcer Dr James Mongan, Partners has
recently implemented the ‘High-Performing Health-
care System Initiatives’, which are intended to sub-
stantially improve the safety, quality and eﬃciency of
the care delivered throughout the system. A corner-
stone of this eﬀort has been developing the ability to
use clinical data in a variety of ways. Some of the main
ways that data have been used for secondary uses to
date are for clinical audit, pay-for-performance and
clinical research.
The key secondary use stores to date are the Partners
Quality DataWarehouse, led byDr Jonathan Einbinder,
which includes Partners-wide data about key clinical
issues such as diabetes and facilitates clinical audit;15
the Research Patient Data Repository, led by Dr Shawn
Murphy, which includes a wide array of data allowing
identiﬁcation of patients for research;16 and health
insurance claims databases, which allow assessment of
performance on pay-for-performance contracts.
The Quality Data Warehouse supports ad hoc
queries, includes many reports and a summary of
performance or ‘quality dashboard’, and facilitates
population management broadly. Some of the types
of reports (see Figure 1) include reports for asthma,
diabetes, medications prescribed, and the description
of a provider’s panel. The speciﬁc reports for con-
ditions like diabetes (see Figure 2) let a provider
rapidly assess their performance, and drill down to
identify speciﬁc patients if necessary.
The Research Patient Data Repository allows a
provider to identify the number of patients with
speciﬁc combinations of ﬁndings, for example myo-
cardial infarction within a speciﬁc timeframe (see
Figure 3). Then, with the appropriate institutional
review board clearance, the researcher can obtain
patient-level data if necessary.
Not surprisingly, a number of issues have arisen in
each area. For clinical audit, it continues to be chal-
lenging to determine the right denominators. In
particular, some of our systems do not clearly identify
the primary care provider, so that deﬁning a provider’s
panel is challenging. The situation is even worse in
specialty care, as one individual may be seen by
multiple specialists (e.g. cardiologists), and good
mechanisms for identifying who is responsible have
not been deﬁned. Another issue is that when errors are
identiﬁed by providers, we do not have good mech-
anisms in place for repairing them. Getting reports to
individual clinicians has also been challenging. Often
reports are only made available to quality leaders or
department heads, and they may or may not ﬁlter
down to individual providers. Finally, getting pro-
viders to use clinical audit results remains a challenge.
Building trust with providers takes time, and one
observation is that obtaining buy-in requires that
providers be able to drill down to the patient level
for any measure, so that they can for example see
which individual patients are out of compliance.
On the research front, one of the thorniest issues has
been to determine how much de-identiﬁcation to
implement.De-identiﬁcation is essential tomeet privacy
and security concerns, but it also presents technical
challenges and can make it hard to answer certain
research questions. Another issue is how secure to
make access. Initially, this was set up so that only
investigators could access certain things; later, the
application was modiﬁed to allow investigators to
delegate access for many activities, which was much
more practical. Another ongoing issue is what ﬁelds to
include in the database, as investigators are always
requesting more data.
For pay-for-performance, one of the next steps will
be to move from using claims data to extracting
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information from electronic health records (EHRs) to
assess pay-for-performance, which will allow a much
more nuanced and accurate approach than is possible
with claims. For that to be practical, it will also be
essential to improve and reﬁne measures, so that they
can readily be extracted from EHRs.
In conclusion, we believe at Partners that many of
the beneﬁts from the conversion to the EHR will
actually result from secondary uses of clinical data.
Clearly, for this to be achieved, standardisation of data
will be essential. In part as a result, the logistics of using
secondary data today are still complex. In the USA, it
Figure 1 Personal reporting ‘dashboard’
Figure 2 Diabetes report
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seems clear that pay-for-performance will represent
a vital lever for moving forward in this area. None-
theless, there aremany societal issues aroundwhat will
be permissible and what will not, and many of these
issues still need case law.
Secondary uses of primary care
data: perspective from a US
measure developer
National and local eﬀorts are underway in the USA to
use primary care data tomeasure clinical quality at the
individual physician level. The overarching goal for
these national and local eﬀorts is to have: timely,
accurate data at the point of care to inform decision-
making and facilitate patient-centred care; aggregate
data for system-wide analysis; and de-identiﬁed data
to be exported to multiple stakeholders. Signiﬁcant
time and eﬀort are needed to meet this goal; however,
the demand for data and public reporting of quality
measures is immediate. Multiple stakeholders are calling
for the following now:
. all physicians reporting on a common set of
measures
. limited data collection burden
. conﬁdence that data are accurate and reliable.
Several activities are underway to accomplish these
requirements:
1 progress toward a core set of measures
2 integration of measures within EHR systems
3 exploration of alternative data collection methods.
1. National measures: progress
towards a core set
Measure developer
The physician profession is at the forefront of evi-
dence-based, physician-level measure development in
the USA. Since 2000, the American Medical Associ-
ation (AMA) has convened the Physician Consortium
for Performance Improvement1 (Consortium). This
is comprised of over 100 national medical specialty
and state medical societies; the Council of Medical
Specialty Societies; American Board of Medical Spe-
cialties and its member-boards; experts in method-
ology and data collection; the Agency for Healthcare
Research and Quality; and the Centers for Medicare
and Medicaid Services (CMS). To date, the Consor-
tium has developed more than 174 individual measures
in 28 clinical content areas, which address both primary
and specialty care.
Topic selection
Consideration is given to what should be measured
(for example, most frequent, costly conditions), and
which types of measures to use in national programmes.
In the UK, many types of measures (clinical processes,
intermediate clinical outcomes, patient satisfaction,
structural/organisational) are in use as part of the
National Health Service Quality and Outcomes
Figure 3 Research Patient Database query tool
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Framework for general practitioners. In the USA,
many of the initial measures developed for individual
physician use have addressed processes of care that are
under the physician’s control; however, as the science
of performance measurement evolves, measure devel-
opers are increasingly exploring physician-level meas-
ures in other areas of quality.
National recognition
The Consortium’s physician-level measures are gaining
national recognition.Many have been endorsed by the
National Quality Forum (NQF) and selected by the
Ambulatory Care Quality Alliance (AQA). Endorse-
ment by these national multi-stakeholder groups
helps to move the USA toward a core set of perform-
ance measures.
2. Integration of performance measures
into information technology
Information technology (IT) will play a key role in
moving the United States toward national reporting
and feedback on qualitymeasures. However, currently
only about 23.9% of physicians use EHRs in the
ambulatory setting.17 Even among physicians who
do have EHRs, many of the systems do not have the
functionality to query and report on national per-
formance measures, unless the physician practice de-
votes signiﬁcant resources to build this functionality.
To facilitate the integration of measures into EHRs,
the Consortium develops technical speciﬁcations by
deﬁning codes and algorithms for measure calcu-
lation. By way of example, to use one of the measures
in the coronary artery disease (CAD) measurement
set, ‘Beta-Blocker Therapy for Patients with a Prior
Myocardial Infarction’ (see Box 2 for completemeasure)
in a physician practice with an EHR system, the fol-
lowing codes and deﬁnitions are needed:
Patient selection criteria (denominator)
. At least two face-to-face oﬃce visits (CPT1 en-
counter codes)
. Age: 18 years or older (date of birth calculation)
. Documented diagnosis of CAD (ICD-9 codes or
CPT1 cardiac procedure codes) AND documented
prior myocardial infarction [MI] (ICD-9 codes)
. Denominator exclusions: medical reason (such as
contraindication to a medication); patient reason
(such as patient refusal)
Data elements required for numerator
. Documentation of beta-blocker on the medication
list or in physician notes of EHRs, OR searchable
drug code (for example, NDC code).
Dual strategy to facilitate integration of
performance measure
Currently, the AMA Consortium is working toward
national integration of performance measures using
two approaches:
1 working directly with physician practice sites
2 working with EHR system vendors to create uni-
versal functionality.
These two approaches are described in more detail
below.
. Approach 1 (working directly with physician prac-
tice sites). In one of several physician-led projects,
six practice sites with diﬀerent EHR system vendor
products and from diﬀerent regions of the USA
are working collaboratively to collect and report
Box 2 Performance measure for beta-blocker therapy18
Clinical recommendation Performance measure
Beta-blocker therapy is
recommended for all
patients with prior MI
in the absence of
contraindications
(Class I Recommendation,
Level A Evidence)
Percentage of patients with prior MI at any time who were prescribed beta-
blocker therapy
Numerator: Patients who were prescribed beta-blocker therapy
Denominator: All patients with CAD who also have prior MI at any time >18
years of age
Denominator inclusion: Patients with CAD and prior MI
Denominator exclusion:
. Documentation of medical reason(s) for not prescribing beta-blocker
therapy
. Documentation of patient reason(s) for not prescribing beta-blocker therapy
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performance measures for CAD and heart failure
(the project is titled Cardio-HIT and is funded by
the Physician Foundation for Health Systems Excel-
lence). The overarching goals for this project in-
clude: (1) to collect data for performance measures
internally within practice sites for quality improve-
ment; (2) to export de-identiﬁed data for the
performance measures to a centralised data ware-
house for benchmarking; (3) to assess the feasibility,
validity, and reliability of national performance
measures.19,20
. Approach 2 (working with EHR system vendors).
The AMA, National Committee for Quality Assur-
ance, and CMS are co-sponsoring an ongoing
collaborative, which brings EHR system vendors,
developers of clinical performance measures, and
testers of these products to the table. The col-
laborative has two key working groups: one is
addressing the technical issues and challenges of
identifying key data elements for performance
measures in EHR systems, and the other is deﬁning
how measure developers can best make their speci-
ﬁcations available to EHR system vendors and how
performancemeasure data can be exported from the
EHR system.
3. Current alternative to EHR system-
enabled environment
National pay-for-reporting programme
Given that the USA is far from universal adoption of
EHRs, many initial eﬀorts regarding national report-
ing on clinical performance measures operate within
the current administrative claims system. In 2007,
CMS has begun a programme called the Physician
Quality Reporting Initiative (PQRI), in which phys-
icians select up to three measures that are appropriate
for the care they deliver, and report themeasures using
newly-developed administrative codes (CPT1Category
II codes) on claims forms. For example, the CPT
category II code 4006F indicates that beta-blocker
therapy was prescribed.
Summary
From the perspective of a developer of performance
measures, eﬀorts appear to be aligning toward the goal
of having a common set of performance measures for
physicians. Moreover, eﬀorts are underway to achieve
integration of performance measures within EHR
systems. Given the pressures from multiple stake-
holders to accelerate eﬀorts, the federal government
and private sector continue to evaluate alternative
data sources (mostly administrative claims data) until
such time as all physicians are using fully functional
EHR systems or are participating in disease registries.
Secondary uses of primary care
data: chronic disease
management
TheAssociation of AmericanMedical Colleges (AAMC)
sent out a request for collaboration among academic
medical centres. The requests focused on chronic
diseases such as diabetes, asthma and osteoarthritis.
Our medical school, Southern Illinois University
School of Medicine (SIU), was chosen to participate
along with 32 other academic medical schools on care
of patients with chronic disease. SIU chose to work
on diabetes mellitus (DM) type 2. Southern Illinois
University School of Medicine is a state-assisted
school established in 1970 to help the people of central
and southern Illinois inmeeting their healthcare needs
through education, research and service and develop
new models for providing health care in rural areas.
The school has 289 medical students (14% minority/
52%women), 272 residents and 324 full-time, 23 part-
time, and 904 volunteer physicians throughout central
and southern Illinois. The main interest for entry into
the collaboration, aside from the better health of our
patients, was to provide an opportunity for the resi-
dents in family medicine to attain competency in
practice-based learning and improvement. This com-
petency is one of six competencies that residents must
obtain prior to graduation through the Accreditation
Council for Graduate Medical Education (ACGME).
The other ﬁve competencies are as follows; patient
care, medical knowledge, interpersonal and commu-
nication skills, professionalism, and systems-based
practice. The practice-based learning and improve-
ment competency states the residents must be able to
investigate and evaluate their patient care practices,
appraise and assimilate scientiﬁc evidence, and im-
prove their patient care practices. The residents should
be able to do the following:
. analyse practice experience and perform practice-
based improvement activities using a systematic
methodology
. locate, appraise, and assimilate evidence from scien-
tiﬁc studies related to their patients’ health prob-
lems
. obtain and use information about their own popu-
lation of patients and the larger population from
which their patients are drawn
. apply knowledge of study designs and statistical
methods to the appraisal of clinical studies and
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other information on diagnostic and therapeutic
eﬀectiveness
. use information technology to manage informa-
tion, access online medical information, and sup-
port their own education
. facilitate the learning of students and other health-
care professionals.21
To start the data collection and analysis process, an
electronic management system or registry was required.
Our residency did not have an electronicmedical record
system so we chose a registry system called Chronic
Disease Electronic Management System (CDEMS).
CDEMS is a software application developed by the
Washington State Diabetes Prevention and Control
Program in 2002. CDEMS is a Microsoft Access data-
base application designed to assist medical providers
and management in tracking the care of patients with
chronic health conditions. CDEMS is pre-coded to track
diabetes and adult preventive health but is customisable
to change those tracking measures or deﬁne measures
for monitoring other chronic conditions. Printed pro-
gress notes, patient lists, and summary reports gen-
erated from the registry database can alter the way
services are delivered and measure quality improve-
ment eﬀorts.22
The interdisciplinary team of faculty, residents, and
nursing collaborated to support diabetes treatment
for our patients. Components identiﬁed and tracked
through the process included the following:
. community
. self-management
. delivery system design
. organisation of health care
. decision support
. clinical information systems.
Baseline goals for eachmeasurement for the 18-month
studywere collected and run charts to display statistics
were produced using data from CDEMS. Data were
sent to the AAMC monthly to be correlated with the
other medical schools’ data, since all participants use
patient data registries and comparemonthly perform-
ance on a number of measures (such as HbA1c, LDL
cholesterol, tobacco use, and so on) against baseline.
The data provided us with an opportunity to combine
our Journal Club and chart audits along with the
collaborative to enhance the teaching of practice-
based learning. By integrating the Journal Club, chart
audits and results from the collaborative, we were able
to show quickly how we could put evidence-based
medicine into practice and track to see how well we
were doing for our patients.
We had a pilot population of approximately 182
that remained steady during the 18-month study. We
looked at the following data points (see Table 1) and
calculated our current baseline along with a goal for
each measurement.
Some of the secondary outcomes of a quality
improvement process during the collaborative period
included an increased awareness of key clinical meas-
ures of DM care, reinforced interdisciplinary team
approach to the care of patients, and a restructured
Journal Club. The Journal Club articles and review of
the evidence-based literature led us to do a focused
chart audit on that topic in resident and faculty charts.
Having the data available from CDEMS gave us quick
feedback on how well we were doing for our patients
and how close we were to using evidence-based
medicine guidelines in the course of their treatment.
The results of the chart reviews aswell as the run charts
from the collaborative provided the residents with a
practical and clinical demonstration of the need to
properly document in the chart what was being rec-
ommended for the patient. A common complaint
from the residents regarding a poor performance in
some of the measurements was that they knew they
had spoken to the patient about a given topic but since
it wasn’t written down in the chart, it was assumed
that it hadn’t happened. This provided the residents
with a clear example of how important proper docu-
mentation is in patient care. As a constant reminder
we were also going to post statistics in the resident
room for the residents, faculty, and nurses to see and
track the progress throughout the collaborative.
SIU has since purchased an EHR system to better
serve patients and enhance education. Chart audits
were completed prior to our conference day and were
very tedious and so it became quite apparent to the
residents that a well-organised electronic record sys-
tem would make manual chart audits more eﬃcient
and accurate.
Issues arising from these
initiatives
Underlying the various secondary uses of primary care
clinical data are a number of issues:
. Are the data being analysed and used of suﬃciently
high quality to allow decisions to be made based on
them?
. If not, are there ways of improving the quality of
data?
. Are there clinical eﬀects if coding is standardised
across the country?
. Are the data truly comparable across practices – are
they extracted in a comparable way and are there
demographic factors that confound the results?
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. Are there perverse incentives and if so what eﬀect do
they have on direct patient care?
. How can these secondary uses/analyses be fed back
to the providers of the data, and is such feedback
likely to have a positive eﬀect on quality of care?
. Are there security and conﬁdentiality risks once
clinical data are extracted and analysed, and how
can they be mitigated?
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